VINORELBINE TARTRATE FOR INJECTION SOLUTION Canada - English - Health Canada

vinorelbine tartrate for injection solution

pfizer canada ulc - vinorelbine (vinorelbine tartrate) - solution - 10mg - vinorelbine (vinorelbine tartrate) 10mg - antineoplastic agents

Vinorelbine Strides 10mg per ml (1ml vial) Malta - English - Medicines Authority

vinorelbine strides 10mg per ml (1ml vial)

strides arcolab international limited unit 4, metro centre, tolpits lane, watford, hertfordshire, wd 189 ss, united kingdom - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Vinorelbine Strides 10mg per ml (5ml vial) Malta - English - Medicines Authority

vinorelbine strides 10mg per ml (5ml vial)

strides arcolab international limited unit 4, metro centre, tolpits lane, watford, hertfordshire, wd 189 ss, united kingdom - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

VINORELBINE EBEWE 10 mg/1 mL (as tartrate) injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

vinorelbine ebewe 10 mg/1 ml (as tartrate) injection vial

sandoz pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection, concentrated - excipient ingredients: nitrogen; water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Vinorelbine Concentrate for Soln for Inf 10mg/ml Malta - English - Medicines Authority

vinorelbine concentrate for soln for inf 10mg/ml

accord healthcare limited - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Vinorelbine 10 mg/ml concentrate for solution for infusion (1ml vial) Malta - English - Medicines Authority

vinorelbine 10 mg/ml concentrate for solution for infusion (1ml vial)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Vinorelbine 10 mg/ml concentrate for solution for infusion (5ml vial|) Malta - English - Medicines Authority

vinorelbine 10 mg/ml concentrate for solution for infusion (5ml vial|)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

VINORELBINE injection solution concentrate United States - English - NLM (National Library of Medicine)

vinorelbine injection solution concentrate

teva parenteral medicines, inc. - vinorelbine tartrate (unii: 253gqw851q) (vinorelbine - unii:q6c979r91y) - vinorelbine 10 mg in 1 ml

Hospira Vinorelbine Tartrate for injection vial 10 mg/1 mL Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vinorelbine tartrate for injection vial 10 mg/1 ml

hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (nsclc), as a single agent or in combination. it is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. in addition vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vinorelbine tartrate for injection 50 mg/5 ml vial

hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (nsclc), as a single agent or in combination. vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. in addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.